United States
Search    
Include All CSL Behring Country Sites

Medicare Second Quarter 2005 Payment Rates for Plasma-Derived and Recombinant Therapies Continued

Medicare Hospital Outpatient Prospective Payment System (HOPPS)

Below are the payment rates for CY2005:

HCPCS Codes
DESCRIPTION
OPPS UPPER PAYMENT LIMIT
J0256* Alpha1- proteinase inhibitor, per 10mg $3.72
J2792 Rho(D), injection, immune globulin, human, intravenous, Per 100 IUs $17.95
J7190 Factor VIII, anti-hemophilic factor, human, Per IU $0.76
J7192 Factor VIII, anti-hemophilic factor, recombinant, Per IU $1.10
J7193 Factor IX, anti-hemophilic factor, non-recombinant, purified, Per IU $0.98
Q2022 von Willebrand factor complex, Per IU $0.83
Q9941 Injection, immune globulin, lyophilized, Per 1 gram $80.68
Q9942 Injection, immune globulin, lyophilized, Per 10 mg $0.75
Q9943 Injection, immune globulin, non- lyophilized, Per 1 gram $80.68
Q9944 Injection, immune globulin, non-lyophilized, Per 10 mg $0.75

* Alpha1 – proteinase inhibitor therapies may be subject to a quarterly change if deemed necessary by the Secretary of HHS.

Payment rates can be viewed by going to the CMS website at www.cms.hhs.gov/home/aboutcms.asp

For more information on the above listed Medicare Payment rates, please call ZLBBehring’s Toll-Free Reimbursement Answerline at 1-800-676-4266.

Previous: Medicare Second Quarter 2005 Payment Rates for Plasma-Derived and Recombinant Therapies

ZLB Behring assumes no responsibility for the individual interpretation of any material, facts, or references provided within the context of its publication of Reimbursement alert.